ClinicalTrials.govpublic full text
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
acute lymphoblastic leukemia, acute myeloid leukemia, childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia, childhood mixed phenotype acute leukemia, mixed phenotype acute leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 880371
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.